
    
      This is a pilot (preliminary) study. Patients with a diagnosis of TEN will be asked to
      consider participating. The study intervention is a single intravenous dose of remicaide (5
      mg/kg). Standard supportive care will be given. The percentage of patients alive at 30 days
      after treatment with remicaide will be compared to historical controls.
    
  